Company news

PAVmed Inc. news in 2020

PAVmed Inc.'s news releases, calls and decks from 2020, newest first.

View company

PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering

December 21, 2020

PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering

December 17, 2020

PAVmed Announces Registered Direct Offering of its Common Stock

December 10, 2020

PAVmed Reports Third Quarter 2020 Financial Results and Provides Business Update

November 16, 2020

PAVmed to Hold Business Update Conference Call on November 17, 2020

November 1, 2020

PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update

August 17, 2020

PAVmed Secures $7 Million Convertible Note Financing

August 5, 2020

PAVmed to Hold Business Update Conference Call on August 18, 2020

July 27, 2020

PAVmed to Join the Russell 2000® and Russell 3000® Indexes

June 16, 2020

PAVmed Collaborates with Canon on DisappEAR™ Pediatric Ear Tubes

June 2, 2020

PAVmed Reports Preliminary First Quarter 2020 Financial Results and Provides Business Update

May 20, 2020

PAVmed to Hold Business Update Conference Call on May 21, 2020

May 10, 2020

PAVmed Receives FDA 510(k) Clearance for its CarpX™ Minimally Invasive Carpal Tunnel Device

April 20, 2020

PAVmed Reports Preliminary Fourth Quarter 2019 Financial Results and Provides Business Update

April 8, 2020

PAVmed to Hold Business Update Conference Call on April 9, 2020

March 23, 2020

PAVmed Announces FDA 510(k) Re-submission for its CarpX™ Minimally Invasive Carpal Tunnel Device

March 8, 2020

PAVmed Subsidiary Lucid Diagnostics Partners with University of Pennsylvania to Evaluate EsoCheck™ in Eosinophilic Esophagitis (EoE) Patients

March 1, 2020

PAVmed Adds EsoCure™ Esophageal Ablation Device with Patented Caldus™ Technology to Commercial Product Pipeline

February 17, 2020

U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test

February 10, 2020

PAVmed Receives Formal Notification of Nasdaq Continued Listing Compliance

January 12, 2020